Ankur Drugs & Pharma (Delisted) share price history
BSE: 531683
Last traded ₹3.65 on 10 Sep 2013
Delisted on 23 Aug 2017.
Last announcements
The company's own last announcements before its shares stopped trading, routine notices left out.Share news and announcements
Apr 2017
24 Apr · Delisting
Members of the Exchange are hereby notified that in terms of Regulation 22(6) of the Securities and Exchange Board of India (Delisting of Equity Shares) Regulations, 2009 (Regulations), Section 21A of the Securities Contract (Regulations) Act, 1956, Securities Contract Regulations Rules, 1957 and Bye Laws and Regulations of National Stock Exchange of India Limited (Exchange) it has been decided to delist (withdraw the admission to dealings in) equity shares of the Ankur Drugs And Pharma Limited w.e.f. May 12, 2017 as per SEBI (Delisting of Equity Shares) Regulations, 2009.
Results
Standalone; ₹ crore, the charts by years to March, the table by quarter.Quarterly results
Quarter to Dec 2012, against the quarter before
- RevenueRevenue. The pill is the change in revenue against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹36 Crup 1.72%
- Net profitNet profit. Under it, net profit in the quarter before. A change in per cent is not worked out where either period is a loss or nothing.
- −₹41 CrQuarter to Sep 2012: −₹23 Cr
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax.
- −113.1%
Revenue by year
Peak revenue ₹1,067 Cr, year to Mar 2010
Net profit by year, a loss in red
- Net profit
- Loss
A loss in 2 of the 5 years shown
| ₹ crore | Mar 2011 | Jun 2011 | Sep 2011 | Dec 2011 | Mar 2012 | Jun 2012 | Sep 2012 | Dec 2012 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 121 | 43 | 33 | 38 | 38 | 33 | 36 | 36 |
| Net profit | −81 | −35 | −31 | −37 | −120 | −63 | −23 | −41 |
| Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. | −66.6% | −80.1% | −92.2% | −95.1% | −315.1% | −190.8% | −66.1% | −113.1% |
Standalone. The last eight quarters. The latest is shaded.
Where the return came from
Yearly rates to Mar 2012, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | −71.3% | – | – | 0.0% |
| 3 years | −40.0% | – | – | 0.0% |
| 5 years | −40.8% | – | – | 0.0% |
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Earnings growth and the change in P/E are left empty where earnings per share at either end of the window was a loss or is not on record.
Recent sessions
The last 10 trading days to 10 Sep 2013, as traded on BSE.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 10 Sep 2013 | 3.75 | 3.75 | 3.65 | 3.65 | 3.65 | 10,260 |
| 6 Sep 2013 | 3.80 | 4.00 | 3.80 | 3.80 | 3.81 | 14,663 |
| 5 Sep 2013 | 3.85 | 4.00 | 3.75 | 4.00 | 3.95 | 9,225 |
| 4 Sep 2013 | 3.65 | 3.90 | 3.65 | 3.85 | 3.65 | 37,899 |
| 3 Sep 2013 | 3.80 | 4.20 | 3.80 | 3.80 | 3.80 | 18,082 |
| 2 Sep 2013 | 4.00 | 4.20 | 4.00 | 4.00 | 4.10 | 7,474 |
| 30 Aug 2013 | 4.20 | 4.40 | 4.20 | 4.20 | 4.27 | 3,712 |
| 29 Aug 2013 | 4.40 | 4.70 | 4.40 | 4.40 | 4.42 | 4,709 |
| 28 Aug 2013 | 4.60 | 4.60 | 4.60 | 4.60 | 4.60 | 5 |
| 27 Aug 2013 | 4.95 | 4.95 | 4.65 | 4.80 | 4.73 | 629 |
Prices in ₹ per share as traded, not adjusted.
Company details
- Legal name
- Ankur Drugs & Pharma Ltd
- BSE code
- 531683
- ISIN
- INE238D01012
- Listed
- Apr 2001
- Face value
- ₹10
- Former symbols
- ANKURDRUGS
- CIN
- L24230MH1995PLC085410
- Corporate identity number, the registrar of companies' code for it